What is LeMaitre Vascular's D&A?

LeMaitre Vascular (LMAT) reported D&A of $2.62M in Q1 2026.

How has LeMaitre Vascular's D&A changed year-over-year?

LeMaitre Vascular's D&A increased by 2.8% year-over-year, from $2.55M to $2.62M.

What is the long-term trend for LeMaitre Vascular's D&A?

Over 3 years (2022 to 2025), LeMaitre Vascular's D&A has grown at a 3.4% compound annual growth rate (CAGR), from $9.43M to $10.42M.

Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.

LeMaitre Vascular LMAT D&A

D&A at other companies

ITG

Integer HoldingsITGR

$35.01M+17.4%

Merit Medical SystemsMMSI

$30.5M+4.1%

HaemoneticsHAE

$27.32M-3.2%

Baxter InternationalBAX

$237M-4.0%

Becton, Dickinson and CompanyBDX

$563M-0.7%

Edwards LifesciencesEW

$40.9M+11.7%

Other financials

Income statement

See full

Revenue$66.6M+11.2%

Gross profit$48.4M+16.8%

Operating income$17.8M+40.8%

Net income$15.7M+42.4%

EPS (diluted)$0.68+41.7%

Balance sheet

See full

Cash & equivalents$26.9M+6.0%

Total debt$20.9M+20.6%

Total equity$406.6M+17.0%

Total assets$629.5M+13.2%

Cash flow

See full

Operating cash flow$15.1M+67.0%

CapEx$2.8M+101%

Free cash flow$12.3M+60.8%

Valuation

See full

Market cap$2.1B+31.4%

Enterprise value$2.1B+31.6%

P/E33.7×-1.7×

P/S8.2×+1.1×

Profitability

See full

Gross margin72.4%+3.6pp

Operating margin28.5%+5.1pp

Net margin24.3%+4.4pp

FCF margin30.9%+12.7pp

Returns & leverage

See full

Return on equity16.5%+2.8pp

Debt / equity0.1×0.0×

Current ratio14.3×-2.2×

Where this comes from

Reported directly by LeMaitre Vascular in its filing.

Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.

The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LeMaitre Vascular's d&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is LeMaitre Vascular's D&A?: LeMaitre Vascular (LMAT) reported D&A of $2.62M in Q1 2026.
How has LeMaitre Vascular's D&A changed year-over-year?: LeMaitre Vascular's D&A increased by 2.8% year-over-year, from $2.55M to $2.62M.
What is the long-term trend for LeMaitre Vascular's D&A?: Over 3 years (2022 to 2025), LeMaitre Vascular's D&A has grown at a 3.4% compound annual growth rate (CAGR), from $9.43M to $10.42M.
What does D&A mean?: Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.